AI Predicts Chemo Effectiveness Before Breast Surgery
Part of Cancer, Skin clinical trials.
This study uses an AI model to predict how well chemotherapy will work before breast cancer surgery. It looks back at medical records and images from women who have already completed treatment to see if the AI can help guide future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman with invasive breast cancer that has not spread to distant organs (stages II–III).
- You received at least 4 rounds of chemotherapy before having surgery to remove the tumor.
- You had surgery to remove all cancer after chemotherapy.
- You have a biopsy sample (tissue taken before chemotherapy) and a breast MRI taken within 2 weeks before starting chemo.
- You do not have inflammatory breast cancer, cancer in both breasts, or cancer that has spread to other organs (stage IV).
- You have not had any other cancer treatments before surgery besides chemotherapy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether an AI tool can predict how well breast cancer responds to chemotherapy given before surgery. Your tumor sample from a needle biopsy will be analyzed to see if the AI's prediction matches your actual treatment outcome.
This trial uses an artificial intelligence model to predict how well breast cancer responds to neoadjuvant therapy (treatment before surgery). It aims to improve treatment planning by analyzing MRI scans taken before and after therapy.
This trial uses artificial intelligence to analyze images of your tumor tissue to predict if breast cancer might spread to other parts of the body. It may help doctors better understand your individual risk and guide treatment decisions.
This trial uses artificial intelligence to analyze tissue samples and predict how well a targeted therapy called Pyrotinib works for advanced breast cancer. It aims to help doctors choose the best treatment for each patient.
This study looks at how well a computer model can predict if breast cancer will completely respond to chemotherapy before surgery. It is for people with early-stage breast cancer who are about to start neoadjuvant chemotherapy.
This trial tests an artificial intelligence (AI) model that looks at pictures of breast tissue to find cancer. It may help improve early detection and reduce the need for invasive tests.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.